Skip to main content
Log in

Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice

  • Published:
Science in China Series C: Life Sciences Aims and scope Submit manuscript

Abstract

The epidemic of HIV/AIDS is sweeping across the world. It is of great importance to figure out new ways to curb this disease. Epitope-based vaccine is one of these solutions. In this study, a chimeric gene was obtained by combination of a designed HIV-1 multi-epitope gene (MEG) and HIV-1 p24 gene. A recombinant plasmid pUTA2-MEGp24 was then constructed by inserting MEGp24 gene into the downstream of the promoter (ATI-P7.5×20) of fowlpox virus (FPV) transfer vector pUTA2. The recombinant plasmid and wild-type FPV 282E4 strain were then co-transfected into CEF cells and homologous recombination occurred. A recombinant virus expressing HIV-1 protein MEGp24 was screened by genome PCR and Western blot assay. Large scale preparation and purification of the recombinant fowlpox virus (rFPV) were then carried out. BALB/c mice were immunized intramuscularly with the rFPV for three times on day 0, 14 and 42. Mice were executed and sampled one week after the third inoculation. Anti-HIV-1 antibody in serum and Th1 cytokines in the supernatant of cultured spleen cells were assayed by ELISA. The count of T lymphocyte subsets and the CTL activity of spleen lymphocytes were analyzed by flow cytometry and lactate dehydrogenase (LDH) release assay, respectively. The results showed that HIV-1 specific antibody in serum and increased T lymphocyte subsets (CD4+ T, CD8+ T) were detected in the immunization group. CTL target-killing activity and higher secretion of Th1 cytokines (IFN-γ and IL-2) of spleen lymphocytes stimulated by H-2d-restricted CTL peptide were observed in immunized mice. We concluded that the rFPV may induce HIV-1 specific immunity especially cellular immunity in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Borrow P H, Lewicki B H, Hahn G M, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol, 1994, 68: 6103–6110

    PubMed  CAS  Google Scholar 

  2. Musey L J, Hughes T, Schacker T, et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med, 1997, 337: 1267–1274

    Article  PubMed  CAS  Google Scholar 

  3. Novitsky V, Smith U R, Gilbert P, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: Consensus sequence for an AIDS vaccine design? J Virol, 2002, 76(11): 5435–5451

    Article  PubMed  CAS  Google Scholar 

  4. Williamson A L, Marais D, Passmore J A, et al., Human papilloma virus (HPV) infection in Southern Africa: Prevalence, immunity, and vaccine prospects. IUBMB Life, 2002, 53(4–5): 253–258

    Article  PubMed  CAS  Google Scholar 

  5. Mashishi T, Loubser S, Hide W, et al. Conserved domains of subtype C Nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions. AIDS Res Hum Retroviruses, 2001, 17(17): 1681–1687

    Article  PubMed  CAS  Google Scholar 

  6. Li Z J, Jin N Y, Jiang W Z, et al. A new type of multiple-epitope DNA vaccine against HIV. Chin J Microbiol Immunol (in Chinese), 2004, 24(11): 910–913

    CAS  Google Scholar 

  7. Wang H W, Jin N Y, Liu Z, et al. Preparation and identification of the anti-HIV-1 core protein monoclonal antibody. Chin J Cell Mol Immunol (in Chinese), 1998, 14(1): 63–64

    CAS  Google Scholar 

  8. Sambrook J, Russell D W. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001. 1.31–1.162

    Google Scholar 

  9. Olive C, Toth I, Jackson D. Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies. Mini Rev Med Chem, 2001, 1: 429–438

    Article  PubMed  CAS  Google Scholar 

  10. Jackson D, Purcell A, Fitzmaurice C, et al. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer. Curr Drug Targets, 2002, 3: 175–196

    Article  PubMed  CAS  Google Scholar 

  11. Sciutto E, Fragoso G, Manoutcharian K, et al. New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Arch Med Res, 2002, 33: 371–378

    Article  PubMed  CAS  Google Scholar 

  12. Gedvilaite A, Frommel C, Sasnauskas K, et al. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polymavirus major capsid protein. Virology, 2000, 273: 21–35

    Article  PubMed  CAS  Google Scholar 

  13. Zhang L S, Jin N Y, Song Y J, et al. Immune responses of a designed HIV-1 DNA vaccine on rhesus monkeys. Chin Sci Bull, 2006, 51(13): 1571–1577

    Article  CAS  Google Scholar 

  14. Butter C, Sturman T D, Baaten B J, et al. Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2. Avian Pathol, 2003, 32(6): 597–604

    Article  PubMed  CAS  Google Scholar 

  15. Qiao C L, Yu K Z, Jiang Y P, et al. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol, 2003, 32(1): 25–32

    Article  PubMed  CAS  Google Scholar 

  16. Karaca K, Sharma J M, Winslow B J, et al. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: Influence of IFN on protective efficacy and humoral responses of chickens following in ovo-or post-hatch administration of recombinant viruses. Vaccine, 1998, 16(16): 1496–1503

    Article  PubMed  CAS  Google Scholar 

  17. Mehdy Elahi S, Bergeron J, Nagy E, et al. Induction of humoral and cellular immune responses in mice by a recombinant fowlpox virus expressing the E2 protein of bovine viral diarrhea virus. FEMS Microbiol Lett, 1999, 171(2): 107–114

    Article  PubMed  CAS  Google Scholar 

  18. Zhao H L, Jin N Y, Guo Z R, et al. Construction and identification of recombinant fowlpox virus expressing rabies virus glycoprotein. Chin J Vet Sci (in Chinese), 2004, 24(1): 37–39

    Google Scholar 

  19. Jin N Y, Zhang H Y, Yin G F, et al. Construction and immunogenecity of a recombinant fowlpox virus co-expressing FMDV P1-2A and 3Cpro gene. Chin Sci Bull, 2004, 49(6): 576–579

    Article  CAS  Google Scholar 

  20. Anderson R J, Hannan C M, Gilbert S C, et al. Enhanced CD8+ T cell immune responses and protection elicited against plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol, 2004, 172(5): 3094–3100

    PubMed  CAS  Google Scholar 

  21. Tsang K Y, Palena C, Yokokawa J, et al. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res, 2005, 11(4): 1597–1607

    Article  PubMed  CAS  Google Scholar 

  22. Hutchings C L, Gilbert S C, Hill A V, et al. Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity. J Immunol, 2005, 175(1): 599–606

    PubMed  CAS  Google Scholar 

  23. Pamungkas J, De Rose R, Iskandriati D, et al. Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques. AIDS Res Hum Retroviruses, 2005, 21(4): 292–300

    Article  PubMed  CAS  Google Scholar 

  24. Parks R J, Krell P J, Derbyshire J B, et al. Studies of fowlpox virus recombination in the generation of recombinant vaccines. Virus Res, 1994, 32(3): 283–297

    Article  PubMed  CAS  Google Scholar 

  25. Borrow P, Lewicki H, Hahn H, et al. Virus-specific CD8+ cytotoxicity T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol, 1994, 68: 6103–6110

    PubMed  CAS  Google Scholar 

  26. Lubaki N M, Shepherd M E, Brookmeyer R S, et al. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38DR-phenotype: Comparison of statistical methods for measurement. J Acquir Immune Defic Syndr, 1999, 22(1): 19–30

    PubMed  CAS  Google Scholar 

  27. Romagnani S. The Th1/Th2 paradigm. Immunol Today, 1997, 18(6): 263–267

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jin NingYi.

Additional information

Supported by the China “863” Program (Grant No. 2003AA219051)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Jin, N., Song, Y. et al. Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice. SCI CHINA SER C 50, 212–220 (2007). https://doi.org/10.1007/s11427-007-0017-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-007-0017-1

Keywords

Navigation